Clinical Trial Update: A Study in Relapse Prevention of Treatment-Resistant Depression [Phase 3]

View source ↗

Summary

A Phase 3 relapse-prevention trial for treatment-resistant depression completed, with results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder Treatment-resistant

Snippet

Sponsor: Eli Lilly and Company | Conditions: Treatment Resistant Depression | Phase 3 | Status: COMPLETED | Results posted: 2014-04-01